No abstract available
MeSH terms
-
Antibodies, Monoclonal, Humanized / therapeutic use
-
Antineoplastic Agents, Immunological / therapeutic use*
-
B7-H1 Antigen / antagonists & inhibitors
-
Carcinoma, Transitional Cell / drug therapy*
-
Carcinoma, Transitional Cell / pathology
-
Carcinoma, Transitional Cell / surgery
-
Chemotherapy, Adjuvant
-
Cystectomy / methods
-
Drug Therapy, Combination / methods
-
Humans
-
Immunotherapy
-
Interleukin-2 / analogs & derivatives
-
Interleukin-2 / therapeutic use
-
Neoplasm Invasiveness
-
Neoplasm Staging
-
Nivolumab / therapeutic use
-
Polyethylene Glycols / therapeutic use
-
Programmed Cell Death 1 Receptor / antagonists & inhibitors
-
Urinary Bladder Neoplasms / drug therapy*
-
Urinary Bladder Neoplasms / pathology
-
Urinary Bladder Neoplasms / surgery
Substances
-
Antibodies, Monoclonal, Humanized
-
Antineoplastic Agents, Immunological
-
B7-H1 Antigen
-
Interleukin-2
-
Programmed Cell Death 1 Receptor
-
Nivolumab
-
Polyethylene Glycols
-
atezolizumab
-
bempegaldesleukin
-
pembrolizumab